Technology
Health
Pharmaceutical

Kala Pharmaceuticals

$4.00
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$0.02 (-0.50%) Today
$0.00 (0.00%) As of 4:00 PM EDT after-hours

Why Robinhood?

You can buy or sell KALA and other stocks, options, ETFs, and crypto commission-free!

About KALA

Kala Pharmaceuticals, Inc. Common Stock, also called Kala Pharmaceuticals, is a biopharmaceutical company, focused on the development and commercialization of therapeutics using proprietary nanoparticle-based Mucus Penetrating Particles, or MPP, technology, with an initial focus on the treatment of eye diseases. Read More The company was founded by Justin Hanes, Robert S. Langer and Colin R. Gardner in 2009 and is headquartered in Waltham, MA.

Employees
130
Headquarters
Waltham, Massachusetts
Founded
2009
Market Cap
136.03M
Price-Earnings Ratio
Dividend Yield
0.00
Average Volume
653.43K
High Today
$4.12
Low Today
$3.93
Open Price
$4.03
Volume
322.56K
52 Week High
$14.45
52 Week Low
$3.92

Collections

Technology
Health
Pharmaceutical
Biopharmaceutical
Therapy
2017 IPO
US
North America

KALA Earnings

-$0.76
-$0.63
-$0.50
-$0.37
Q4 2017
Q1 2018
Q2 2018
Q3 2018
Q4 2018
Q1 2019
Q2 2019
Estimated
-$0.73 per share
Actual
-$0.70 per share
All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.